PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28057599-8	2017	The in vivo effects of aspirin plus sorafenib on cisplatin therapy were also confirmed in resistant HNC xenograft models, in terms of growth inhibition, GSH depletion, and increased gammaH2AX formation and apoptosis in tumors.	Sorafenib	36-45	H2A.X variant histone	Mus musculus	182-191